Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer

Published:2009-09 Issue:9 Volume:4 Page:1075-1082
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Qi Yingwei,Schild Steven E.,Mandrekar Sumithra J.,Tan Angelina D.,Krook James E.,Rowland Kendrith M.,Garces Yolanda I.,Soori Gamini S.,Adjei Alex A.,Sloan Jeff A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference46 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. NCI. Cancer Statistics Review 1975–2002.

3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group;BMJ,1995

4. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

5. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience;Albain;J Clin Oncol,1991

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis and risk factor assessment of patients with advanced lung cancer with low socioeconomic status: model development and validation;BMC Cancer;2024-09-10

2. Global quality of life and mortality risk in patients with cancer: a systematic review and meta-analysis;Quality of Life Research;2024-05-29

3. Trends and predictors of Quality of Life in lung cancer survivors;Lung Cancer;2024-05

4. Pretreatment quality of life and survival in patients with lung cancer: a systematic review and meta-analysis;BMC Cancer;2024-04-18

5. Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB–IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trial;Journal of Thoracic Disease;2022-11